# Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer

> **NCT01060501** · PHASE3 · COMPLETED · sponsor: **University of Ulm** · enrollment: 796 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Folinic Acid, interferon-alpha

## Key facts

- **NCT ID:** NCT01060501
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 796 (ACTUAL)
- **Last updated:** 2010-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060501, "Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01060501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*